Safety Alerts: An Observational Study in Portugal.

Detalhes bibliográficos
Autor(a) principal: Soares, Sara
Data de Publicação: 2015
Outros Autores: Roque, Fátima, Teixeira Rodrigues, António, Figueiras A, Adolfo, Herdeiro, Maria Teresa
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10314/3142
Resumo: PURPOSE: The information that is available when marketing authorizations are approved is limited. Pharmacovigilance has an important role during the postauthorization period, and alerts published by national authorities allow health care professionals to be informed about new data on safety profiles. This study therefore sought to analyze all safety alerts published by the Portuguese National Authority of Medicines and Health Products I.P. (INFARMED). METHODS: We conducted an observational study of all alerts published on the INFARMED website from January 2002 through December 2014. From the data included in the alerts, the following information was abstracted: active substance name (and trade name), event that led to the alert, and the resulting safety measures. Active substances were classified according to the Anatomical Therapeutic Chemical (ATC) code. FINDINGS: A total of 562 alerts were published, and 304 were eligible for inclusion. The musculoskeletal system was the ATC code with more alerts (n = 53), followed by the nervous system (n = 42). Communication of the information and recommendations to the health care professionals and the public in general was the most frequent safety measure (n = 128), followed by changes in the Summary of the Product Characteristics and package information leaflet (n = 66). During the study period, 26 marketing authorizations were temporarily suspended and 10 were revoked. IMPLICATIONS: The knowledge of the alerts published during the postmarketing period is very useful to the health care professionals for improving prescription and use of medicines and to the scientific community for the development of new researches. Copyright © 2015 Elsevier HS Journals, Inc. All rights reserved.
id RCAP_10217c55e9eebfc2aa9241bf8b973f49
oai_identifier_str oai:bdigital.ipg.pt:10314/3142
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Safety Alerts: An Observational Study in Portugal.National Regulatory Agencyadverse drug reactionsPortugalpharmacovigilancesafety alertssafety measuresPURPOSE: The information that is available when marketing authorizations are approved is limited. Pharmacovigilance has an important role during the postauthorization period, and alerts published by national authorities allow health care professionals to be informed about new data on safety profiles. This study therefore sought to analyze all safety alerts published by the Portuguese National Authority of Medicines and Health Products I.P. (INFARMED). METHODS: We conducted an observational study of all alerts published on the INFARMED website from January 2002 through December 2014. From the data included in the alerts, the following information was abstracted: active substance name (and trade name), event that led to the alert, and the resulting safety measures. Active substances were classified according to the Anatomical Therapeutic Chemical (ATC) code. FINDINGS: A total of 562 alerts were published, and 304 were eligible for inclusion. The musculoskeletal system was the ATC code with more alerts (n = 53), followed by the nervous system (n = 42). Communication of the information and recommendations to the health care professionals and the public in general was the most frequent safety measure (n = 128), followed by changes in the Summary of the Product Characteristics and package information leaflet (n = 66). During the study period, 26 marketing authorizations were temporarily suspended and 10 were revoked. IMPLICATIONS: The knowledge of the alerts published during the postmarketing period is very useful to the health care professionals for improving prescription and use of medicines and to the scientific community for the development of new researches. Copyright © 2015 Elsevier HS Journals, Inc. All rights reserved.Clinical Therapeutics2016-11-15T02:30:05Z2016-11-152015-09-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10314/3142http://hdl.handle.net/10314/3142engdoi: 10.1016/j.clinthera.2015.07.015Soares, SaraRoque, FátimaTeixeira Rodrigues, AntónioFigueiras A, AdolfoHerdeiro, Maria Teresainfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-01-14T02:56:34Zoai:bdigital.ipg.pt:10314/3142Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T01:42:32.946279Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Safety Alerts: An Observational Study in Portugal.
title Safety Alerts: An Observational Study in Portugal.
spellingShingle Safety Alerts: An Observational Study in Portugal.
Soares, Sara
National Regulatory Agency
adverse drug reactions
Portugal
pharmacovigilance
safety alerts
safety measures
title_short Safety Alerts: An Observational Study in Portugal.
title_full Safety Alerts: An Observational Study in Portugal.
title_fullStr Safety Alerts: An Observational Study in Portugal.
title_full_unstemmed Safety Alerts: An Observational Study in Portugal.
title_sort Safety Alerts: An Observational Study in Portugal.
author Soares, Sara
author_facet Soares, Sara
Roque, Fátima
Teixeira Rodrigues, António
Figueiras A, Adolfo
Herdeiro, Maria Teresa
author_role author
author2 Roque, Fátima
Teixeira Rodrigues, António
Figueiras A, Adolfo
Herdeiro, Maria Teresa
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Soares, Sara
Roque, Fátima
Teixeira Rodrigues, António
Figueiras A, Adolfo
Herdeiro, Maria Teresa
dc.subject.por.fl_str_mv National Regulatory Agency
adverse drug reactions
Portugal
pharmacovigilance
safety alerts
safety measures
topic National Regulatory Agency
adverse drug reactions
Portugal
pharmacovigilance
safety alerts
safety measures
description PURPOSE: The information that is available when marketing authorizations are approved is limited. Pharmacovigilance has an important role during the postauthorization period, and alerts published by national authorities allow health care professionals to be informed about new data on safety profiles. This study therefore sought to analyze all safety alerts published by the Portuguese National Authority of Medicines and Health Products I.P. (INFARMED). METHODS: We conducted an observational study of all alerts published on the INFARMED website from January 2002 through December 2014. From the data included in the alerts, the following information was abstracted: active substance name (and trade name), event that led to the alert, and the resulting safety measures. Active substances were classified according to the Anatomical Therapeutic Chemical (ATC) code. FINDINGS: A total of 562 alerts were published, and 304 were eligible for inclusion. The musculoskeletal system was the ATC code with more alerts (n = 53), followed by the nervous system (n = 42). Communication of the information and recommendations to the health care professionals and the public in general was the most frequent safety measure (n = 128), followed by changes in the Summary of the Product Characteristics and package information leaflet (n = 66). During the study period, 26 marketing authorizations were temporarily suspended and 10 were revoked. IMPLICATIONS: The knowledge of the alerts published during the postmarketing period is very useful to the health care professionals for improving prescription and use of medicines and to the scientific community for the development of new researches. Copyright © 2015 Elsevier HS Journals, Inc. All rights reserved.
publishDate 2015
dc.date.none.fl_str_mv 2015-09-01T00:00:00Z
2016-11-15T02:30:05Z
2016-11-15
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10314/3142
http://hdl.handle.net/10314/3142
url http://hdl.handle.net/10314/3142
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv doi: 10.1016/j.clinthera.2015.07.015
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Clinical Therapeutics
publisher.none.fl_str_mv Clinical Therapeutics
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799136918482452480